Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Liraglutide for Bipolar Disorder
Recruiting0 awardsPhase 2
Mason, Ohio
This trial will test whether liraglutide, a medication used to treat diabetes, can help reduce weight and improve metabolism in obese or overweight patients with bipolar disorder without worsening psychiatric symptoms.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.